Carl Zeiss Meditec AG (AFX) — Cash Flow-to-Debt Ratio
Carl Zeiss Meditec AG (AFX) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of €144.16 Million could theoretically repay 0% of its total liabilities (€1.28 Billion) in one year. See financial agility of Carl Zeiss Meditec AG to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Carl Zeiss Meditec AG Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Carl Zeiss Meditec AG across 12 annual periods. For the full cash flow conversion analysis, see Carl Zeiss Meditec AG (AFX) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Carl Zeiss Meditec AG (2014–2025)
Year-by-year debt coverage analysis for Carl Zeiss Meditec AG. Check how high is Carl Zeiss Meditec AG's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | €209.86 Million | €1.28 Billion | ▼ -11.1% |
| 2024 | 0.19x | €247.32 Million | €1.34 Billion | ▼ -36.6% |
| 2023 | 0.29x | €250.86 Million | €860.02 Million | ▲ +22.9% |
| 2022 | 0.24x | €188.20 Million | €792.73 Million | ▼ -53.0% |
| 2021 | 0.50x | €362.66 Million | €718.59 Million | ▲ +59.1% |
| 2020 | 0.32x | €178.53 Million | €562.73 Million | ▼ -12.6% |
| 2019 | 0.36x | €219.63 Million | €605.17 Million | ▼ -32.6% |
| 2018 | 0.54x | €187.21 Million | €347.42 Million | ▲ +444.6% |
| 2017 | 0.10x | €37.73 Million | €381.37 Million | ▼ -64.9% |
| 2016 | 0.28x | €111.77 Million | €396.57 Million | ▲ +69.8% |
| 2015 | 0.17x | €56.74 Million | €341.84 Million | ▼ -25.1% |
| 2014 | 0.22x | €63.10 Million | €284.88 Million | — |